Intelicare Holdings Limited

CHIA:ICR Stock Report

Market Cap: AU$4.9m

Intelicare Holdings Valuation

Is ICR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ICR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate ICR's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ICR's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ICR?

Key metric: As ICR is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for ICR. This is calculated by dividing ICR's market cap by their current revenue.
What is ICR's PS Ratio?
PS Ratio17.2x
SalesAU$284.11k
Market CapAU$4.87m

Price to Sales Ratio vs Peers

How does ICR's PS Ratio compare to its peers?

The above table shows the PS ratio for ICR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average8.2x
TD1 TALi Digital
22.5xn/aAU$4.9m
GLH Global Health
0.9xn/aAU$7.8m
TRI TrivarX
7.7xn/aAU$6.9m
VFX Visionflex Group
1.7xn/aAU$11.7m
ICR Intelicare Holdings
17.2xn/aAU$4.9m

Price-To-Sales vs Peers: ICR is expensive based on its Price-To-Sales Ratio (17.2x) compared to the peer average (11x).

Price to Sales Ratio vs Industry

How does ICR's PS Ratio compare vs other companies in the AU Healthcare Services Industry?

7 CompaniesPrice / SalesEstimated GrowthMarket Cap
MDR MedAdvisor
1.3x13.4%US$103.31m
DOC Doctor Care Anywhere Group
0.3x6.3%US$15.72m
IME ImExHS
0.7x20.5%US$10.51m
VFX Visionflex Group
1.7xn/aUS$7.58m
ICR 17.2xIndustry Avg. 3.2xNo. of Companies7PS0816243240+
7 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: ICR is expensive based on its Price-To-Sales Ratio (17.2x) compared to the Global Healthcare Services industry average (3.1x).

Price to Sales Ratio vs Fair Ratio

What is ICR's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ICR PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio17.2x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate ICR's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

SDI

AU$131.3m

Engages in the research and development, manufacture, and marketing of dental restorative materials, whitening systems, and other dental materials in Australia, Europe, the United States, and Brazil.

SDI

AU$1.10

7D

2.3%

1Y

45.7%

Doctor Care Anywhere Group

AU$24.2m

Provides digital healthcare and development services in the United Kingdom, Australia, and the Republic of Ireland.

DOC

AU$0.064

7D

-1.5%

1Y

36.2%

CardieX

AU$30.9m

Engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific.

CDX

AU$0.10

7D

-8.7%

1Y

n/a